![slide set](http://s1.studyres.com/store/data/000125783_1-39e5220ee2ae731e01b3882a1811d4dc-300x300.png)
slide set
... I love medical oncology because it is a particularly exciting time with the expansion of targeted and immunotherapies. We have the opportunity to use these cutting edge treatments for patient benefit. There have been dramatic improvements in treatment and I'm excited to see that continuing ...
... I love medical oncology because it is a particularly exciting time with the expansion of targeted and immunotherapies. We have the opportunity to use these cutting edge treatments for patient benefit. There have been dramatic improvements in treatment and I'm excited to see that continuing ...
Blood and Hematopoiesis - Johns Hopkins Medicine
... The appearance of normal circulating blood is relatively uniform with little variation in size and shape. Red blood cells will have an area of paleness in the center, which is approximately one-third the diameter of the cell. Maslak, P. ASH Image Bank 2008;2008:8-00044. Copyright ©2008 American Soci ...
... The appearance of normal circulating blood is relatively uniform with little variation in size and shape. Red blood cells will have an area of paleness in the center, which is approximately one-third the diameter of the cell. Maslak, P. ASH Image Bank 2008;2008:8-00044. Copyright ©2008 American Soci ...
Serine and Cysteine Proteases and Their Inhibitors as Antimicrobial
... provide ligands for the MHC class II-restricted antigenic pathway. MHC class II molecules access the endolysosomal compartments to bind peptides and display them on the surface of DCs to trigger CD4+ T-cell response. Indeed, the uptake of exogenous antigen into DCs is followed by protease-mediated d ...
... provide ligands for the MHC class II-restricted antigenic pathway. MHC class II molecules access the endolysosomal compartments to bind peptides and display them on the surface of DCs to trigger CD4+ T-cell response. Indeed, the uptake of exogenous antigen into DCs is followed by protease-mediated d ...
2,6-sialylated Fc
... 120 different glycoproteins in the IVIG preparation terminal sugar residues of sialic acid confers anti-inflammatory p 1-3% of IgGs in IVIG have sFc (sialylation) recombinant sFc: enhanced 35 fold of action in vivo Carbohydrate Carbohydrate-Binding Proteins ...
... 120 different glycoproteins in the IVIG preparation terminal sugar residues of sialic acid confers anti-inflammatory p 1-3% of IgGs in IVIG have sFc (sialylation) recombinant sFc: enhanced 35 fold of action in vivo Carbohydrate Carbohydrate-Binding Proteins ...
Diapositiva 1
... both adaptive and innate, causing crypts hypertrofia and villus atrophy Diagnosis: antibodies anti TTG and anti endomisium Biopsy Therapy: Life long total abstinence from gluten containing food ...
... both adaptive and innate, causing crypts hypertrofia and villus atrophy Diagnosis: antibodies anti TTG and anti endomisium Biopsy Therapy: Life long total abstinence from gluten containing food ...
Understanding the interaction between psychosocial stress
... humans supporting these observations was, however, lacking. Studies published in the last 2 decades in Brain, Behavior and Immunity and other journals have demonstrated that acute and chronic psychological stress can induce pronounced changes in innate and adaptive immune responses and that these ch ...
... humans supporting these observations was, however, lacking. Studies published in the last 2 decades in Brain, Behavior and Immunity and other journals have demonstrated that acute and chronic psychological stress can induce pronounced changes in innate and adaptive immune responses and that these ch ...
Clarithromycin Treatment of Bacteremia Produced by Mycoplasmas
... mycoplasma with the host cell membrane may also result in the hydrolysis of host cell phospholipids catalyzed by the potent membrane bound phospholipases present in many mycoplasma species. This could trigger specific signal cascades or release cytolytic phospholipids capable of disrupting the integ ...
... mycoplasma with the host cell membrane may also result in the hydrolysis of host cell phospholipids catalyzed by the potent membrane bound phospholipases present in many mycoplasma species. This could trigger specific signal cascades or release cytolytic phospholipids capable of disrupting the integ ...
facilities where specimens are collected, and are typically located in
... Esoteric tests are those tests that require more sophisticated technology, equipment or materials, professional “hands-on” attention from highly skilled and technical personnel, and that may be performed less frequently than routine tests. Because it is not cost-effective for most hospital and clini ...
... Esoteric tests are those tests that require more sophisticated technology, equipment or materials, professional “hands-on” attention from highly skilled and technical personnel, and that may be performed less frequently than routine tests. Because it is not cost-effective for most hospital and clini ...
The testis in immune privilege
... Impairment of blood–testis barrier integrity has been observed during inflammation, infection, and trauma, which ultimately results in germ cell loss (76–79). Mechanistically, elevated levels of tumor necrosis factor-a (TNF-a) and transforming growth factor-b (TGF-b), found in systemic and local tes ...
... Impairment of blood–testis barrier integrity has been observed during inflammation, infection, and trauma, which ultimately results in germ cell loss (76–79). Mechanistically, elevated levels of tumor necrosis factor-a (TNF-a) and transforming growth factor-b (TGF-b), found in systemic and local tes ...
Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme
... responsible for Lyme disease, the most common ticktransmitted illness of the boreal hemisphere (1,2). In Europe, Lyme disease is caused by Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii, whereas in the US, Borrelia burgdorferi is the sole cause (3,4). Lyme disease usually begins with a ...
... responsible for Lyme disease, the most common ticktransmitted illness of the boreal hemisphere (1,2). In Europe, Lyme disease is caused by Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii, whereas in the US, Borrelia burgdorferi is the sole cause (3,4). Lyme disease usually begins with a ...
Proft Lecture
... • P28 causes N-terminal tails of the -subunits to flip upwards, thereby facilitating substrate entry and product exit. • The immunoproteasome does not replace the constitutive proteasome completely • The immunoproteasome has a considerably shorter half-life • The immunoproteasome has an altered cle ...
... • P28 causes N-terminal tails of the -subunits to flip upwards, thereby facilitating substrate entry and product exit. • The immunoproteasome does not replace the constitutive proteasome completely • The immunoproteasome has a considerably shorter half-life • The immunoproteasome has an altered cle ...
CELL SURFACE ENZYMES IN CONTROL OF LEUKOCYTE
... Other enzymes that are involved in the degradation and synthesis of extracellular nucleotides can also be involved in leukocyte migration. For example, nucleotide pyrophosphatases and nucleotide phosphodiesterases hydrolyse pyrophosphate and phosphodiester bonds in nucleotides, respectively, which r ...
... Other enzymes that are involved in the degradation and synthesis of extracellular nucleotides can also be involved in leukocyte migration. For example, nucleotide pyrophosphatases and nucleotide phosphodiesterases hydrolyse pyrophosphate and phosphodiester bonds in nucleotides, respectively, which r ...
Primary Immunodeficiency and Autoimmunity: Lessons From Human
... develops in the same individual. As outlined in the current review, this contention clearly holds true in certain cases, particularly in deficiencies involving T-regulatory cells, components of the classical pathway of complement and defects in lymphocyte apoptosis. Furthermore, it is also important ...
... develops in the same individual. As outlined in the current review, this contention clearly holds true in certain cases, particularly in deficiencies involving T-regulatory cells, components of the classical pathway of complement and defects in lymphocyte apoptosis. Furthermore, it is also important ...
induction of nasopharyngeal mucosal immune responses in the horse
... on day 21 and in all 3 on day 49. The absence of a systemic response may have been due to failure of release by antigen from the mucosal compartment. Lack of potency has been frequently associated with microencapsulation as a mode of mucosal antigen delivery and so the technology has not been widely ...
... on day 21 and in all 3 on day 49. The absence of a systemic response may have been due to failure of release by antigen from the mucosal compartment. Lack of potency has been frequently associated with microencapsulation as a mode of mucosal antigen delivery and so the technology has not been widely ...
Recombinant Human Erythropoietin (EPO) (carrier-free)
... -PH is a sensor of levels of iron, oxygen, and metabolic activity. High levels of HIF protein induce EPO production in the kidney and liver, and mobilization of iron to support erythropoiesis. EPO binds to the EPOR, and transcripts of this receptor have been detected in non-erythroid precursors such ...
... -PH is a sensor of levels of iron, oxygen, and metabolic activity. High levels of HIF protein induce EPO production in the kidney and liver, and mobilization of iron to support erythropoiesis. EPO binds to the EPOR, and transcripts of this receptor have been detected in non-erythroid precursors such ...
ILO`s and lecture objectives-HMIM 224(2013
... Identify the clinical picture and laboratory diagnosis of acute myeloid leukemia (AML). Summarize the clinical features and laboratory characteristics of B-cell chronic lymphocytic leukemia (B-cell CLL) Recognize the clinical picture and laboratory findings of chronic myeloid leukemia (CML). ...
... Identify the clinical picture and laboratory diagnosis of acute myeloid leukemia (AML). Summarize the clinical features and laboratory characteristics of B-cell chronic lymphocytic leukemia (B-cell CLL) Recognize the clinical picture and laboratory findings of chronic myeloid leukemia (CML). ...
Primary B-Cell Deficiencies Reveal a Link between Human IL
... IL-17 is a pro-inflammatory cytokine implicated in autoimmune and inflammatory conditions. The development/survival of IL-17-producing CD4 T cells (Th17) share critical cues with B-cell differentiation and the circulating follicular T helper subset was recently shown to be enriched in Th17 cells abl ...
... IL-17 is a pro-inflammatory cytokine implicated in autoimmune and inflammatory conditions. The development/survival of IL-17-producing CD4 T cells (Th17) share critical cues with B-cell differentiation and the circulating follicular T helper subset was recently shown to be enriched in Th17 cells abl ...
An Analytical Approach to Modulating Effects of Heat Shock Proteins
... genetic disease arises from accumulation of mutations in critical genes. There are no unilateral reasons for its development. However, some proteins have by this time been identified for the development of cancer in human body. On the other hand, some proteins namely Heat shock proteins (Hsp) are in ...
... genetic disease arises from accumulation of mutations in critical genes. There are no unilateral reasons for its development. However, some proteins have by this time been identified for the development of cancer in human body. On the other hand, some proteins namely Heat shock proteins (Hsp) are in ...
Public health messages impact on adolescent girls: misperceptions
... • 226,870 new cases of invasive breast cancer will be diagnosed 2012 (ACS, 2012). • The etiology of a portion of these are modifiable behaviors. • Risk and protective behaviors are learned, adopted, or experimented with during adolescence. • Behaviors are a function of misperceived or misunderstood ...
... • 226,870 new cases of invasive breast cancer will be diagnosed 2012 (ACS, 2012). • The etiology of a portion of these are modifiable behaviors. • Risk and protective behaviors are learned, adopted, or experimented with during adolescence. • Behaviors are a function of misperceived or misunderstood ...
Food Sensitivity Testing_Alcat vs IgG antibodies
... (not pro-inflammatory) following exposure to food components and therefore indicate a tolerance, not intolerance (9, 10, 12, 13). Some laboratories investigate the presence of IgG1-3 antibodies or total IgG titers against foods- but is this clinically useful? The IgG subclasses 1-3 can play a role i ...
... (not pro-inflammatory) following exposure to food components and therefore indicate a tolerance, not intolerance (9, 10, 12, 13). Some laboratories investigate the presence of IgG1-3 antibodies or total IgG titers against foods- but is this clinically useful? The IgG subclasses 1-3 can play a role i ...
PPT - Larry Smarr - California Institute for Telecommunications and
... Despite decades of research, the etiology of Crohn's disease remains unknown. Its pathogenesis may involve a complex interplay between host genetics, immune dysfunction, and microbial or environmental factors. --The Role of Microbes in Crohn's Disease ...
... Despite decades of research, the etiology of Crohn's disease remains unknown. Its pathogenesis may involve a complex interplay between host genetics, immune dysfunction, and microbial or environmental factors. --The Role of Microbes in Crohn's Disease ...
Characterization of Major Structural Proteins of Measles
... Delineation of non-overlapping antigenic sites by competitive antibody binding Antigenic sites to which the monoclonal antibodies bound were analysed by competitive binding assays. Binding of peroxidase-conjugated antibodies to the solid phase antigen was determined in the absence and presence of va ...
... Delineation of non-overlapping antigenic sites by competitive antibody binding Antigenic sites to which the monoclonal antibodies bound were analysed by competitive binding assays. Binding of peroxidase-conjugated antibodies to the solid phase antigen was determined in the absence and presence of va ...
Cancer immunotherapy
![](https://commons.wikimedia.org/wiki/Special:FilePath/Peptide_bound_to_Rituximab_FAB.png?width=300)
Cancer immunotherapy (immuno-oncology) is the use of the immune system to treat cancer. Immunotherapies fall into three main groups: cellular, antibody and cytokine. They exploit the fact that cancer cells often have subtly different molecules on their surface that can be detected by the immune system. These molecules, known as cancer antigens, are most commonly proteins, but also include molecules such as carbohydrates. Immunotherapy is used to provoke the immune system into attacking the tumor cells by using these antigens as targets.Antibody therapies are the most successful immunotherapy, treating a wide range of cancers. Antibodies are proteins produced by the immune system that bind to a target antigen on the cell surface. In normal physiology the immune system uses them to fight pathogens. Each antibody is specific to one or a few proteins. Those that bind to cancer antigens are used to treat cancer. Cell surface receptors are common targets for antibody therapies and include the CD20, CD274, and CD279. Once bound to a cancer antigen, antibodies can induce antibody-dependent cell-mediated cytotoxicity, activate the complement system, or prevent a receptor from interacting with its ligand, all of which can lead to cell death. Multiple antibodies are approved to treat cancer, including Alemtuzumab, Ipilimumab, Nivolumab, Ofatumumab, and Rituximab.Cellular therapies, also known as cancer vaccines, usually involve the removal of immune cells from the blood or from a tumor. Immune cells specific for the tumor are activated, cultured and returned to the patient where the immune cells attack the cancer. Cell types that can be used in this way are natural killer cells, lymphokine-activated killer cells, cytotoxic T cells and dendritic cells. The only cell-based therapy approved in the US is Dendreon's Provenge, for the treatment of prostate cancer.Interleukin-2 and interferon-α are examples of cytokines, proteins that regulate and coordinate the behaviour of the immune system. They have the ability to enhance anti-tumor activity and thus can be used as cancer treatments. Interferon-α is used in the treatment of hairy-cell leukaemia, AIDS-related Kaposi's sarcoma, follicular lymphoma, chronic myeloid leukaemia and malignant melanoma. Interleukin-2 is used in the treatment of malignant melanoma and renal cell carcinoma.